Proteome-Wide Analysis Using SOMAscan Identifies and Validates Epidermal Growth Factor as a Disease Marker of Collagenous GastritisDebora Curci, Towia A. Libermann, Harland S. Winter et al.|Gastro Hep Advances|2022Cited by 3
P307 Novel proteomic analysis of 11,000 serum proteins distinguishes between Crohn’s disease and ulcerative colitis in pediatric patientsM. Wu, Towia A. Libermann, Simon T. Dillon et al.|Journal of Crohn s and Colitis|2024Cited by 1
P192 Personalizing treatment for predicting response to infliximab in children with Crohn’s disease using proteomic biomarkersHarland S. Winter, Towia A. Libermann, Prateek Wali et al.|Journal of Crohn s and Colitis|2024Cited by 1
Sa1767 – Somascan As a Discovery Platform to Identify Predictive Serum Proteomic Biomarkers of Infliximab Response in Pediatric Patients with Crohn's DiseaseTina L. Morhardt, Harland S. Winter, Towia A. Libermann et al.|Gastroenterology|2019Cited by 0